ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...

Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.

Here are the best-performing Aristocrats in 2025: The Dividend Aristocrats started out 2026 on a hot note with NOBL earning a 5.67% gain in January, far outpacing SPY that only managed a gain of 1.47% ...

Kirby Corporation has resilient margins, 10-20% upside, and broad 2026 guidance with marine and D&S segment pressure. Check out why KEX stock is a buy.

Seasonally Adjusted Money Supply has been growing on a consistent monthly basis since November 2023 (26 straight months). Read more here.

Powell Industries, Inc. reports $1.1B revenue and a $1.3B backlog with 28.2% ROE and no debt in FY25. Check out why POWL ...

Electro Optic Systems Holdings has a A$579m backlog and a $9.67 fair value with 63% upside in C-UAS lasers. Find out why EOPSF stock is a buy.

While Warsh is expected to eventually be confirmed by the Senate, the process may not be entirely straightforward. Read more here.

The European cannabis wholesale business was weak in Q4 due to transitory disruption in Portugal. Remexian's performance should recover. The ecommerce segment has continued to weaken High Tide's ...

The outlook is less bleak than a year ago, thanks to trade's resilience, but the impact of the emerging global order will be felt in 2026. Read more here.

Federal government enters partial shutdown as Senate passes funding bill; House vote Monday may reopen agencies.

Palantir Technologies Inc. shares rose 1,800% as backward-looking analysis missed AI trends and unique growth. Find out why PLTR stock is a hold.